Oral Mucositis - Epidemiology Insights to 2025

Publisher Name :
Date: 01-Aug-2017
No. of pages: 68
Price : Single User: US $ 2950  US $ 2360 Corporate User: US $ 8850  US $ 5310
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Oral Mucositis - Epidemiology Forecast To 2025" report provides an overview of the disease and global historical and forecasted epidemiological data of Oral Mucositis for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan till 2025.

Oral Mucositis is considered as one of the most common oral problems associated with cancer therapy. It is reported that Oral mucositis occurs in up to 20% to 40% of adult cancer patients receiving conventional chemotherapy for solid tumors, about 80% of patients receiving high-dose chemotherapy before haematopoietic stem cell transplantation, and almost all patients receiving radiotherapy for head and neck cancer. The Oral mucositis also occurs in the 70% of the patients with cancers of the mouth, oropharynx, hypopharynx, larynx, nasopharynx, and salivary glands. It has been reported that approximately 500,000 cases of oral mucositis occurs in U.S. The incidence of oral mucositis varies across populations of patients with cancer and is related to individual patient factors and the type of therapy being received.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house forecast model analysis by the team of industry experts.

Scope

- The report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options

- The report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2015-2025

- The report includes the overall incidence, grade specific, gender specific and indication specific incidence of Oral Mucositis in the 7MM- United States, EU5 (France, Germany, Italy, Spain and UK) and Japan

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Oral Mucositis - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

Overview
Oral Mucositis Incidence
Pathophysiology
Etiology and Risk Factors
Oral Mucositis Complications
Symptoms
Diagnosis
Interventions for Oral Mucositis
Chemotherapy Induced Oral Mucositis Treatment and Prevention
Treatment and Prevention Options for Patients receiving Hematopoietic Stem Cell Transplantation (HSCT)

Epidemiology Overview
Key Findings

Epidemiology of Oral Mucositis in 7 MM
Assumptions and Rationale
Incident Population of Oral Mucositis in 7MM
United States
Assumptions and Rationale
Incident Cases of Oral Mucositis in US
Grade Specific Incidence of Oral Mucositis in US
Gender Specific Incidence of Oral Mucositis in US
Indication Specific Incidence of Oral Mucositis in US
EU5
Assumptions and Rationale
France
Assumptions and Rationale
Incident Cases of Oral Mucositis in France
Grade Specific Incidence of Oral Mucositis in France
Gender Specific Incidence of Oral Mucositis in France
Indication Specific Incidence of Oral Mucositis in France
Germany
Assumptions and Rationale
Incident Cases of Oral Mucositis in Germany
Grade Specific Incidence of Oral Mucositis in Germany
Gender Specific Incidence of Oral Mucositis in Germany
Indication Specific Incidence of Oral Mucositis in Germany
Italy
Assumptions and Rationale
Incident Cases of Oral Mucositis in Italy
Grade Specific Incidence of Oral Mucositis in Italy
Gender Specific Incidence of Oral Mucositis in Italy
Indication Specific Incidence of Oral Mucositis in Italy
Spain
Assumptions and Rationale
Incident Cases of Oral Mucositis in Spain
Grade Specific Incidence of Oral Mucositis in Spain
Gender Specific Incidence of Oral Mucositis in Spain
Indication Specific Incidence of Oral Mucositis in Spain
United Kingdom
Assumptions and Rationale
Incident Cases of Oral Mucositis in United Kingdom
Grade Specific Incidence of Oral Mucositis in United Kingdom
Gender Specific Incidence of Oral Mucositis in United Kingdom
Indication Specific Incidence of Oral Mucositis in United Kingdom
Japan
Assumptions and Rationale
Incident Cases of Oral Mucositis in Japan
Grade Specific Incidence of Oral Mucositis in Japan
Gender Specific Incidence of Oral Mucositis in Japan
Indication Specific Incidence of Oral Mucositis in Japan
Appendix

List of Tables

Table 1: Incident Population of Oral Mucositis in 7MM (2015-2025)
Table 2: Incident Population of Oral Mucositis in United States (2015-2025)
Table 3: Grade Specific Incidence of Oral Mucositis in United States (2015-2025)
Table 4: Gender Specific Incidence of Oral Mucositis in United States (2015-2025)
Table 5: Indication Specific Incidence of Oral Mucositis in United States (2015-2025)
Table 6: Incident Population of Oral Mucositis in France (2015-2025)
Table 7: Grade Specific Incidence of Oral Mucositis in France (2015-2025)
Table 8: Gender Specific Incidence of Oral Mucositis in France (2015-2025)
Table 9: Indication Specific Incidence of Oral Mucositis in France (2015-2025)
Table 10: Incident Population of Oral Mucositis in Germany (2015-2025)
Table 11: Grade Specific Incidence of Oral Mucositis in Germany (2015-2025)
Table 12: Gender Specific Incidence of Oral Mucositis in Germany (2015-2025)
Table 13: Indication Specific Incidence of Oral Mucositis in Germany (2015-2025)
Table 14: Incident Population of Oral Mucositis in Italy (2015-2025)
Table 15: Grade Specific Incidence of Oral Mucositis in Italy (2015-2025)
Table 16: Gender Specific Incidence of Oral Mucositis in Italy (2015-2025)
Table 17: Indication Specific Incidence of Oral Mucositis in Italy (2015-2025)
Table 18: Incident Population of Oral Mucositis in Spain (2015-2025)
Table 19: Grade Specific Incidence of Oral Mucositis in Spain (2015-2025)
Table 20: Gender Specific Incidence of Oral Mucositis in Spain (2015-2025)
Table 21: Indication Specific Incidence of Oral Mucositis in Spain (2015-2025)
Table 22: Incident Population of Oral Mucositis in United Kingdom (2015-2025)
Table 23: Grade Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
Table 24: Gender Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
Table 25: Indication Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
Table 26: Incident Population of Oral Mucositis in Japan (2015-2025)
Table 27: Grade Specific Incidence of Oral Mucositis in Japan (2015-2025)
Table 28: Gender Specific Incidence of Oral Mucositis in Japan (2015-2025)
Table 29: Indication Specific Incidence of Oral Mucositis in Japan (2015-2025)


List of Figures

Figure 1: Incident Population of Oral Mucositis in 7MM (2015-2025)
Figure 2: Incident Population of Oral Mucositis in United States (2015-2025)
Figure 3: Grade Specific Incidence of Oral Mucositis in United States (2015-2025)
Figure 4: Gender Specific Incidence of Oral Mucositis in United States (2015-2025)
Figure 5: Indication Specific Incidence of Oral Mucositis in United States (2015-2025)
Figure 6: Incident Population of Oral Mucositis in France (2015-2025)
Figure 7: Grade Specific Incidence of Oral Mucositis in France (2015-2025)
Figure 8: Gender Specific Incidence of Oral Mucositis in France (2015-2025)
Figure 9: Indication Specific Incidence of Oral Mucositis in France (2015-2025)
Figure 10: Incident Population of Oral Mucositis in Germany (2015-2025)
Figure 11: Grade Specific Incidence of Oral Mucositis in Germany (2015-2025)
Figure 12: Gender Specific Incidence of Oral Mucositis in Germany (2015-2025)
Figure 13: Indication Specific Incidence of Oral Mucositis in Germany (2015-2025)
Figure 14: Incident Population of Oral Mucositis in Italy (2015-2025)
Figure 15: Grade Specific Incidence of Oral Mucositis in Italy (2015-2025)
Figure 16: Gender Specific Incidence of Oral Mucositis in Italy (2015-2025)
Figure 17: Indication Specific Incidence of Oral Mucositis in Italy (2015-2025)
Figure 18: Incident Population of Oral Mucositis in Spain (2015-2025)
Figure 19: Grade Specific Incidence of Oral Mucositis in Spain (2015-2025)
Figure 20: Gender Specific Incidence of Oral Mucositis in Spain (2015-2025)
Figure 21: Indication Specific Incidence of Oral Mucositis in Spain (2015-2025)
Figure 22: Incident Population of Oral Mucositis in United Kingdom (2015-2025)
Figure 23: Grade Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
Figure 24: Gender Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
Figure 25: Indication Specific Incidence of Oral Mucositis in United Kingdom (2015-2025)
Figure 26: Incident Population of Oral Mucositis in Japan (2015-2025)
Figure 27: Grade Specific Incidence of Oral Mucositis in Japan (2015-2025)
Figure 28: Gender Specific Incidence of Oral Mucositis in Japan (2015-2025)
Figure 29: Indication Specific Incidence of Oral Mucositis in Japan (2015-2025)
  • Global Human Growth Hormone (hGH) Market Research Report 2017
    Published: 14-Dec-2017        Price: US 2900 Onwards        Pages: 100
    In this report, the global Human Growth Hormone (hGH) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Growth Hormone (hGH) in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global Acromegaly Treatment Market Size, Status and Forecast 2022
    Published: 14-Dec-2017        Price: US 3300 Onwards        Pages: 99
    This report studies the global Acromegaly Treatment market, analyzes and researches the Acromegaly Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Pfizer Inc - Chiasma Inc - Novartis AG - Ipsen Biopharmaceuticals Inc - Wockhardt Ltd - Troikaa Pharmaceuticals Limited - VHB Life Sciences Limited - GlaxoSmithKline plc ......
  • Global Acyl CoA Desaturase Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the global Acyl CoA Desaturase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Acyl CoA Desaturase for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japa......
  • Global Enteric Softgel Capsules Market Research Report 2017
    Published: 14-Dec-2017        Price: US 2900 Onwards        Pages: 106
    In this report, the global Enteric Softgel Capsules market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Enteric Softgel Capsules in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - ......
  • Global Combination Vaccine Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the global Combination Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Combination Vaccine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japa......
  • Global Axial Spondyloarthritis Drugs Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the global Axial Spondyloarthritis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Axial Spondyloarthritis Drugs for these regions, from 2012 to 2022 (forecast), covering - United States - China - ......
  • Global Dermatomyositis Drug Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 116
    In this report, the global Dermatomyositis Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Dermatomyositis Drug for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Ja......
  • Global Erythropoietin Drugs Sales Market Report 2017
    Published: 14-Dec-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the global Erythropoietin Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K ML), revenue (Million USD), market share and growth rate of Erythropoietin Drugs for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Jap......
  • United States Anti-Fungal Agents Market Report 2017
    Published: 14-Dec-2017        Price: US 3800 Onwards        Pages: 101
    In this report, the United States Anti-Fungal Agents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs